SC 13G Filing

Company

Atea Pharmaceuticals, Inc.

Filed

October 2, 2023

Accession Number

0001616824-23-000007

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →